| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fluticasone | FAERS: 6 | US FAERS | |
| 2 | Guaifenesin | FAERS: 2 | US FAERS | |
| 3 | Anoro Ellipta | FAERS: 1 | US FAERS | |
| 4 | Bevespi Aerosphere | FAERS: 1 | US FAERS | |
| 5 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 6 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 7 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 8 | Loratadine | FAERS: 1 | US FAERS | |
| 9 | N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide | FAERS: 1 | US FAERS | |
| 10 | NuvaRing | FAERS: 1 | US FAERS | |
| 11 | Olopatadine Hydrochloride | FAERS: 1 | US FAERS | |
| 12 | carfilzomib | FAERS: 1 | US FAERS | |
| 13 | levocetirizine | FAERS: 1 | US FAERS | |
| 14 | valbenazine | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.